Glycosyltransferases are useful synthetic catalysts for generating natural products with sugar moieties. Although several natural product glycosyltransferase structures have been reported, design principles of glycosyltransferase engineering for the generation of glycodiversified natural products has fallen short of its promise, partly due to a lack of understanding of the relationship between structure and function. Here, we report structures of all four calicheamicin glycosyltransferases (CalG1, CalG2, CalG3, and CalG4), whose catalytic functions are clearly regiospecific. Comparison of these four structures reveals a conserved sugar donor binding motif and the principles of acceptor binding region reshaping. Among them, CalG2 possesses a unique catalytic motif for glycosylation of hydroxylamine. Multiple glycosyltransferase structures in a single natural product biosynthetic pathway are a valuable resource for understanding regiospecific reactions and substrate selectivities and will help future glycosyltransferase engineering. N atural products with antibiotic and/or anticancer activities are a valuable pharmaceutical resource (1) . Sugar moieties in these natural products are often critical to a given metabolite's biological activity and can impact the delivery of the natural product to the target, present high affinity and specificity for a given target, as well as modulate both mechanism and in vivo properties of the natural product (2) . Due to these roles, altering the sugar moieties utilizing promiscuous or engineered glycosyltransferases (GTs) represents a prominent method for redesigning natural products for pharmacological applications (3) (4) (5) (6) . The crystal structures of GTs and, more specifically, an intricate understanding of how GTs achieve regio-and stereospecific reactions, will guide structure-based design and help to interpret the outcomes of directed evolution (7, 8) . However, due to the lack of substrate bound GT structures, these engineering methods have thus far been only successful in very limited cases (9, 10) .
Calicheamicin γ 1 I (CLM), the flagship member of the naturally occurring 10-membered enediynes, provides a unique model for interrogating the regiochemistry of GTs (11) . While an iterative type I polyketide synthase in conjunction with tailoring enzymes provide the novel enediyne core (12) (13) (14) , four unique GTs are required to complete the biosynthesis of the CLM aryltetrasaccharide, composed of four novel sugar moieties and an orsellinic acid-like moiety (Fig. 1) . Some CLM GTs are highly promiscuous and can perform forward, reverse, and exchange reactions, enabling chemoenzymatic methods to generate glycodiversified CLM analogs (15, 16) . Based upon biochemical studies, CalG1 and CalG4 were found to be external GTs, acting as a rhamnosyltransferase for sugar moiety D and as an aminopentosyltransferase for sugar moiety E, respectively. Alternatively, CalG2 and CalG3 were characterized as internal GTs, acting as a thiosugartransferase for sugar moiety B and as a hydroxylaminoglycosyltransferase for sugar moiety A, respectively (Fig. 1) . Previously, a CalG3 unliganded structure was reported (16) ; however, the absence of substrates in the model prevented understanding of the binding mode of CLM and identification of the origins of regiospecificity.
Here, we report the ligand-bound CalG3, CalG2, CalG1, and unliganded CalG4 structures and complete the GT structure analysis of CLM biosynthetic pathway. The entire set of CLM GT structures reveal a conserved CLM coordination motif among this GT set as well as the key features that dictate the different binding modes of the substrates and the resulting distinct regiospecific reactions. In addition, this comprehensive GT structural study is anticipated help guide future GT engineering efforts.
Results
Overall Structure Description and Donor Molecule Binding in the C-Terminal Domain of CLM GTs. The crystal structure of CalG3 with thymidine diphosphate (TDP) and CLM T 0 (Fig. 1 ) was solved to a resolution of 1.6 Å ( Fig. 2A and Table S1 ); CalG2 with TDP and CLM T 0 was solved to a resolution of 2.2 Å (Fig. 2B and  Table S1 ); CalG4 in an unliganded form was solved to a resolution of 1.9 Å (Fig. 2C and Table S2 ); and CalG1 with TDP and CLM α 3 I ( Fig. 1 ) was solved to a resolution of 2.3 Å (Fig. 2D  and Tables S1 and S2 ). Despite their low sequence identities ( Fig. S1 A and B) , all CLM GTs adopt a conserved GT-B fold, with the N-terminal and C-terminal domains forming a Rossmann fold connected by a linker region. All substrate bound structures adopt a "closed" conformation, while previous CalG3 and CalG4 unliganded structures demonstrate an "open" conformation (Fig. S2) . With the exception of some variability in CalG2, the TDP molecule is bound in a highly conserved manner in the C-terminal domain through π-stacking interactions with tryptophan side chain and through hydrogen bonds with nitrogen and oxygen atoms of the polypeptide backbone (Fig. S3 ). This structural consistency implies that the main causes of regiospecificity among the structures are within the acceptor binding regions of the proteins.
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( Fig. 2A and Fig. S4A ). CLM T 0 is recognized by three specific aromatic residues, which define a distinct CLM recognition motif (17) (Fig. 3A) . The planar imidazole side chain of His11, a catalytic residue, is orthogonal to the enediyne plane, and the position of Nϵ2 of His11 is near the center of the 10-membered ring of CLM T 0 , forming a cation-π interaction. Phe60 is orthogonal to another face of the ring, pointing toward one of the conjugated single bonds of the enediyne, showing a CH-π or edge-to-face interaction. Phe310 forms a π-stacking interaction with the cyclohexenone, although this ring is slightly tilted with respect to the plane. Most of these residues adopt different conformations in the unliganded structure and show evidence of either conformational selection or induced fit (Fig. 3A) . The methylated trisulfide CalG3 complex structure (green) and unliganded structure (silver) with the key residues that recognize the 10-membered enediyne moiety and cyclohexenone (orange). The side chain of His11 rotates 90°and the Phe60 side chain undergoes a flip upon acceptor binding. The rotation of His11 forms a hydrogen bond between the two catalytic residues to facilitate the glycosyltransfer reaction. (B) CalG2 complex structure (magenta). Phe67, Tyr80, and His77 are utilized for coordination of the enediyne moiety (orange). Thr238 or Asp325 is proposed as a catalytic residue. (C) CalG4 structure (light orange) overlaid with the CLM in CalG2 structure (silver) Tyr82, Trp146, and His79 are proposed to be involved in the coordination of CLM. Phe60, Phe63, or His64 are also proposed to be involved in the coordination of CLM via induced fit. Catalytic residues are His16 and Asp108. (D) CalG1 complex structure (cyan). The aryltetrasaccharide moiety is located in the hydrophobic cleft between the two domains and Phe90 is involved in a π-stacking interaction with moiety C. The small box in the upper left corner in all figures represent the whole structure and the black box indicate the region that is zoomed in. N and C means N-terminal and C-terminal domains, respectively.
group is surrounded by hydrophobic residues (Fig. S4A) . The Glu/Asp-Gln pair, which has been proposed as a determinant of the donor sugar specificity (18, 19) , is not conserved in CalG3. Only Gln311 remains and interacts with sugar A (C2-OH in the sugar A with Nϵ2 of Gln311, and C3-OH in the sugar A with Oϵ1) (Fig. S5A ).
CalG2 Acceptor Binding Mode. Although CalG2 and CalG3 are closely related functionally (the product of CalG3 is the substrate of CalG2), the binding mode of CLM T 0 in CalG2 is clearly distinct, binding within a hydrophobic cavity in the N-terminal domain ( Fig. 2B and Fig. S4B ). Among three specific aromatic residues that coordinate the CLM enediyne moiety in the CalG3 structure, only two of them are identified in the CalG2 structure (Fig. 3B ). Phe67 points toward the center of the 10-membered ring forming a CH-π interaction, and Tyr80 forms a π-stacking interaction with the cyclohexenone, corresponding to His11 and Phe310 of CalG3, respectively. Also, there is a hydrogen bond between a hydroxyl group in the enediyne ring and His77. The methylated trisulfide is again located in the hydrophobic region that is surrounded by the N3 loop and α helix. There is no direct interaction between sugar A and the surrounding CalG2 residues. Asp325 remains in the Glu/Asp-Gln pair; however, its role is not clear due to the lack of a donor sugar moiety in the structure (Fig. S5B ).
CalG4 Acceptor Binding Mode. Because of the highly similar conformations of the N3 and N5 regions (Fig. S6A) , which is the most important determinant of acceptor molecule binding, the CLM binding mode in CalG4 can be predicted from the overlay of the CalG2 structure on the CalG4 structure (Fig. 3C ). Tyr82 and His79 of CalG4 are in the same position as Tyr80 and His77 of CalG2. The Phe67 residue of CalG2, involved in a CH-π interaction with the enediyne moiety, is not conserved in CalG4; however, Phe60, Phe63, or His64 might take a similar role via an induced fit upon substrate binding. Besides these residues, Trp146 is proposed to coordinate the enediyne moiety by pointing a conjugated single bond, similar to Phe60 of CalG3. Although the same aglycon binding modes are expected in both CalG2 and CalG4, sugar A needs to be adjusted in CalG4 to bring its O2 reactive group close to the catalytic residue, His16. When sugar A is adjusted in the CalG4 model, not only will O2 be pointing toward the catalytic residue, but also the hydroxylamine of C4 will be pointing toward the cleft between the two domains. This means that the C4 position has the capacity to accommodate an extra moiety and thus explains why the CalG4 reaction is promiscuous for CLM variants at this position (15) .
CalG1 Acceptor Binding Mode. In the CalG1 structure, CLM α 3 I was seen bound in the hydrophobic cleft between the N-terminal and C-terminal domains (Fig. 2D) . The electron density for sugar D is missing, presumably removed by the CalG1 reverse reaction (Fig. S4C) . Unlike CalG3, CalG2, and possibly CalG4, CalG1 mainly utilizes the aryltetrasacchride of CLM for substrate coordination (Fig. 3D ). Phe90 forms a π-π stacking interaction with the C moiety and is considered one of the essential residues for the coordination of that aromatic ring. The C2 OH group in sugar A points outward, which explains why the CalG1 reaction does not discriminate among CLM sugar E variants (15) . The enediyne is located at the opening of the cleft in the solvent exposed area and does not have direct interactions with CalG1. The trisulfide is located in the hydrophobic region, generated by the Nα3a and Nα3b helices, similar to other CLM GTs. Again, the Glu/AspGln pair is not conserved in CalG1 (Fig. S5D) . Only Asp319 is present in the conserved region, implying possible interactions with the equatorial C4-OH of sugar D, which might provide for a wide range of donor sugar promiscuity.
Active Site Architecture. CalG1, CalG3, and CalG4 utilize a catalytic dyad, histidine and aspartate, located in the cleft between the two domains, which is highly conserved in other GTs (19) (20) (21) (22) (Fig. 3 A, C, and D and Fig. S6B ). The low barrier hydrogen bond formation between Asp and His side chains will facilitate nucleophilic attack on the acceptor hydroxyl group in the CLM via a serine hydrolase-like mechanism (23) (24) (25) . In the case of CalG2, Leu14 takes the typical position of histidine, whose catalytic activity is missing due to a lack of nucleophilicity, which indicates a different mechanism in CalG2, or a different nucleophile (Fig. 3B  and Fig. S6B ). Based on the distance from the hydroxylamine group in sugar A to the CalG2 residues, candidates for the catalytic residues of CalG2 are either Thr238 or Asp325 (3.9 Å and 2.4 Å, respectively). However, Asp325 is present in the Glu/AspGln motif, which interacts with the transferring sugar in other CLM GTs (18, 19) and is thus not unique to CalG2.
Discussion
All four CLM GT structures adopt the same GT-B fold and donor molecule binding region and demonstrate good alignment despite quite low sequence identities (Fig. S1 A and B) . The principles for the coordination of the acceptor molecule are conserved. Enediyne coordination is accomplished via interactions with three aromatic residues (or two in CalG2) (Fig. 3) . Also, the residues that accommodate the methyltrisulfide serve to "protect" the methyltrisulfide from reductive activation, thus preventing a premature Bergman cycloaromatization event. Despite these similarities, the acceptor molecule binding region of the CLM GTs displays specialization, demonstrated by the N-terminal domains, most notably by the N3 and N5 regions (α-helices and loops located between strands β3 and β4, β5 and β6, respectively) ( Fig. 4 and Fig. S1 ), that display strong sequence and structural variation in which, in turn, invokes functional differentiation.
Differentiation of CalG3/CalG1 and CalG2/CalG4 Functions. Based on their acceptor molecule binding modalities, CalG3 and CalG1 can be grouped together as using a "bi-domain" binding mode (22) and CalG2 and CalG4 can be grouped together as using an "N-terminal cavity" binding mode (19) (20) (21) . The determinant of the binding mode is driven by the presence or absence of a cavity produced by the N3 and N5 regions. In the "bi-domain" binding mode of CalG3 and CalG1, there is only one Nα5 helix, which is very close to the Nα3c helix, contributing to the lack of space between the N3 and N5 regions, in turn requiring a different acceptor molecule binding region (Fig. 4 A and D) . Meanwhile, CalG2 and CalG4 have multiple, long Nα5 helices, which create a substantial cavity between the N3 and N5 regions for acceptor molecule binding (Fig. 4 B and C) . This observation implies that the overall GT structure provides a general catalytic platform and that the GT chimeras produced by swapping the N3 and N5 regions might contribute to changes in the acceptor regiospecificity and increased reaction promiscuity. This contention is further supported by prior mutagenesis studies that implicate the N3 and N5 loops as influencing reaction specificity (26) (27) (28) .
Differentiation of CalG3 and CalG1. CalG3 and CalG1 function as internal and external GTs, respectively. The key residues to build the different binding site architectures and invoke an internal vs. external reaction are Pro95 and Phe152 of CalG3 in the middle of the N3c helix and the N5 helix, respectively, which act as a "helix breaker." Due to these two residues, CalG3 adopts bent N3c and N5 helices, which contribute to the creation of a "smaller" acceptor binding space (Fig. 4A) . On the other hand, CalG1 has linear N3c and N5 helices, which form a straight wall within the cleft between the two domains and coordinate a lengthy substrate (Fig. 4D) . Therefore, residues remote from the active sites con-tribute to the different architectures of substrate binding and also influence the regiospecificity of the reactions. Electrostatic properties are another determinant of the differential binding mode (Fig. S6 C and D) . CalG1 has slightly negatively charged residues in the CalG3 trisulfide moiety binding region, which is governed by hydrophobic residues. This feature prevents CalG1 from possible CalG3 substrate (calicheamicinone) binding. The N-terminal domain cavities of other natural product GTs are also dominated by hydrophobic residues.
Differentiation of CalG2 and CalG4. Due to the expected similarity of the acceptor molecule binding modes in CalG2 and CalG4, catalytic residue relocation in CalG2 compared to CalG4 is utilized to achieve the regiospecificity (Fig. 3 B and C and Fig. S6 ). The nucleophile on the acceptor of CalG2 is a hydroxylamine, which is more reactive than the typical hydroxyl group (pKa of 13.7 vs. 15 ∼ 16). Therefore, CalG2 appears not to need the usual catalytic dyad, and Thr238 or Asp325 may mediate the reaction.
Phylogenetic Origins of CLM GTs. All CLM GTs have been assigned to the GT-1 family in the CAZy database (29) . Phylogenetic analysis of the bacterial GT-1 family suggests that while most GTs in the same pathway are highly related, CLM GTs might have been derived from distant ancestor genes (Fig. S1C ). CalG2 and CalG4 likely originate from a relatively recent common ancestor sequence, as expected from their sequential and structural similarity. However, CalG3 and CalG1 likely come from a much more distant phylogenetic origin than CalG2 and CalG4. An attempt to predict different binding modes or to identify "helix breaker" residues from the phylogenetic tree, alignment of sequences, or predicted secondary structure elements failed to produce recognizable patterns.
Conclusion
CLM GTs are prime examples of how structurally homologous enzymes achieve their regiospecific reactions and thereby contribute to diverse chemical reactivities. The set of GT structures in the CLM biosynthetic pathway possess the conserved CLM coordination signature (Fig. 3) ; CalG3, CalG2, and CalG4 utilize three (or two) aromatic residues for the enediyne coordination through cation-π and/or CH-π interaction and π stacking interaction. The dispositions of these residues in each GTare different in order to accommodate different acceptor molecule positions and regiospecific reactions. CalG1 is distinguished from other CLM GTs because there is no direct interaction with the enediyne core. In this report, we show that fundamental determinants of acceptor molecule binding are localized in the N3 and N5 regions (CalG1, CalG3 vs. CalG2, CalG4), which suggest that mutating and exchanging these regions would be best place to focus engineering. Also, two "helix breaker" residues of CalG3 (Pro95 and Phe152), electrostatic charges (CalG3 vs. CalG1) and catalytic residue reorientation (CalG2 vs. CalG4) are able to contribute to the further regiospecific functional differentiation among the four CLM GTs (Fig. 5) . The lesson from the CLM GT structures explains not only the common principle of enzymes in natural product biosynthesis pathway but also provides various possible methods for the rational design of the alteration of GT specificities. showing pairs of GTs and their specified adaptations. CalG3 and CalG1 share 28% sequence identity and have their acceptor bound between the two domains, and CalG2 and CalG4 share 49% sequence identity and have their acceptor bound internally. In CalG3, the N3c and N5 helices are bent by two helix breaker residues. In CalG2, catalytic residues are altered for the hydroxylamine glycosidic bond linkage.
Methods
Sample Preparation. CLM α 3 I was provided by Pfizer. CLM T 0 was prepared as previously described (16) . CalG3, CalG2, and CalG1 with TDP samples were prepared by mixing 10 mg∕mL of CalG3 or 20 mg∕mL of CalG2 or CalG1 protein samples with 25 mM TDP. For preparing CalG3, CalG2, or CalG1 with TDP and CLM T 0 or α 3
I , approximately 0.1 mg of CLM powder were dissolved in 5 μL 100% methanol, then added to 20 μL of CalG3, CalG2 or CalG1 protein with TDP sample prepared above, before methanol evaporated. Samples were centrifuged at max speed for 10 s to remove precipitated CLM and make fully saturated CalG3, CalG2, or CalG1 with TDP and CLM T 0 or α 3 I solutions. Supernatants were taken out and clear but tint red color was observed. All crystal screens are set up with these supernatants.
X-ray Crystallography. Initial screens were performed with a local screen UW192, IndexHT, and SaltHT (Hampton research) utilizing a Mosquito® dispenser (TTP labTech) by the sitting drop method. Crystal growth was monitored by Bruker Nonius Crystal Farms at 20°C and 4°C.
CalG3 with TDP and CLM T 0 crystals were grown by mixing 1 μL of sample solution and 1 μL of reservoir solution, 28% MEPEG 2K, 160 mM Na 3 Citrate, and 100 mM NaAcetate pH 4.5 at 20°C using hanging drop method. CalG2 with TDP and CLM T 0 crystals were grown by mixing 1 μL of sample solution and 1 μL of reservoir solution, 0.5% MEPEG 5K, 800 mM Na K-tartrate, and 100 mM Tris pH 8.5 at 20°C using hanging drop method. CalG2 with TDP crystals were grown by mixing 10 μL of sample solution and 10 μL of reservoir solution, 800 mM Na 3 Citrate and 100 mM BisTris pH 6.5 at 20°C using batch method. CalG4 crystals were grown by mixing 1 μL of sample solution and 1 μL of reservoir solution, 20% PEG 4K, 80 mM CaCl 2 , 100 mM Arg-Glu, and 100 mM CHES pH 9.5 at 4°C using hanging drop method. Streak seeding was utilized to provide diffraction-quaility crystals. CalG1 with TDP and CLM α 3 I crystals were grown by mixing 1 μL of sample solution and 1 μL of reservoir solution, 16% MEPEG 5 K, 160 mM CaCl 2 , and 100 mM MES/Acetate pH 5.5 at 20°C using hanging drop method. CalG1 with TDP crystals were grown by mixing 1 μL of sample solution and 1 μL of reservoir solution, 20% PEG3350, 0.2 M LiSO 4 , 100 mM BisTris pH 6.5 at 20°C using hanging drop method. All crystals were cryoprotected with reservoir solution and 20% ethylene glycol except CalG2 with TDP and CLM T 0 crystal, which were protected by fomblin, and were flash frozen in liquid nitrogen. Cryosolutions of CalG2 with TDP and CalG1 with TDP require an additional 10 mM TDP. Datasets were indexed and scaled using HKL2000 (30) . CalG2/TDP/CLM dataset displays a lattice translocation disorder and requires special treatment (31, 32) (SI Text and Fig. S7 ). For phasing experiments (CalG4, CalG1/TDP), phenix.HySS (33) and ShelxD (34) were utilized for determining the selenium substructures, autoSHARP for phasing (35) , DM for density modification (36) , and phenix.autobuild for automatic model building (33) . For CalG3 with bound TDP and CLM T 0 structures, molecular replacement was used with a separated N-terminal domain (1-200) and C-terminal domain (201-375) using the previously determined CalG3 structure (PDB ID code 3D0R) as a starting model. For the CalG2 with bound TDP and CLM T 0 structure, molecular replacement was used with the CalG2/TDP structure (PDB ID code 3IAA) as a starting model. For the CalG2 with bound TDP structure, molecular replacement was used with a separated N-terminal domain (1-200) and C-terminal domain (201-375) of the CalG4 structure (PDB ID code 3IA7) as a starting model. For the CalG1 with bound TDP and CLM α 3 I , molecular replacement was used starting with the CalG1/TDP structure (PDB ID code 3OTG). phenix.-AutoMR and phenix.AutoBuild were utilized for molecular replacement and model rebuilding (33) . The structures were completed with alternating rounds of manual model building with COOT (37) and refinement with phenix.refine (33) . The final rounds of CalG1 and TDP structure refinement included eight TLS groups (38) . Structure quality was assessed by Procheck (39) and Molprobity (40) . All figures in this paper were generated by PyMOL (41).
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